REGN

REGN R&D Expenses

$6.46BTTM · USD

Period ending:

REGN FY R&D ExpensesUSD
REGN FY R&D Expenses1990-12-31: $0.001991-12-31: $0.001992-12-31: $0.001993-12-31: $0.001994-12-31: $39.70M1995-12-31: $23.30M1996-12-31: $28.30M1997-12-31: $27.80M1998-12-31: $37.00M1999-12-31: $44.90M2000-12-31: $56.26M2001-12-31: $91.54M2002-12-31: $124.93M2003-12-31: $136.02M2004-12-31: $136.10M2005-12-31: $137.92M2006-12-31: $122.12M2007-12-31: $190.13M2008-12-31: $266.73M2009-12-31: $384.52M2010-12-31: $469.57M2011-12-31: $498.42M2012-12-31: $588.61M2013-12-31: $818.74M2014-12-31: $1.22B2015-12-31: $1.55B2016-12-31: $1.95B2017-12-31: $1.93B2018-12-31: $2.04B2019-12-31: $2.24B2020-12-31: $2.50B2021-12-31: $2.62B2022-12-31: $3.06B2023-12-31: $3.99B2024-12-31: $5.23B2025-12-31: $5.85B$5.85B$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

REGN r&d expenses history

Research and development spending. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Regeneron Pharmaceuticals R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
5,850,200,000
5,233,000,000
3,986,700,000
3,056,100,000
2,621,900,000
2,499,100,000
2,239,700,000
2,037,900,000
1,929,675,000
1,947,550,000
1,545,668,000
1,218,667,000
818,743,000
588,614,000
498,424,000
469,565,000
384,515,000
266,728,999
190,126,000
122,122,000
137,922,000
136,095,000
136,024,000
124,926,000
91,540,000
56,256,000
44,900,000
37,000,000
27,800,000
28,300,000
23,300,000
39,700,000
0
0
0
0

Compare r&d expenses

All REGN financial metrics · REGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.